Note 17. Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Compensation Expense Recognized in the Consolidated Statements of Operations

The following table presents share-based compensation expense recognized in our consolidated statements of operations for the years ended December 31, 2025, 2024, and 2023 (in thousands):

	2025		2024		2023
Cost of sales	$	2,649	$	3,923	$	4,798
Selling, general and administrative	13,685		20,696		25,217
Research and development	2,888		3,502		4,133
Production start-up	1		(17)		71
Total share-based compensation expense	$	19,223	$	28,104	$	34,219

Schedule of Restricted Stock and Performance Unit Activity

The following is a summary of our restricted stock unit activity, including performance unit activity, for the year ended December 31, 2025:

	Number of Shares	Weighted-Average Grant-Date Fair Value
Unvested restricted stock units at December 31, 2024	814,338	$	132.00
Restricted stock units granted (1)	233,750	135.49
Restricted stock units vested	(340,563)	91.59
Restricted stock units forfeited	(76,504)	131.25
Unvested restricted stock units at December 31, 2025	631,021	$	155.19

——————————

(1)Restricted stock units granted include the maximum amount of performance units available for issuance under our long-term incentive program for key executive officers and associates. The actual number of shares to be issued will depend on the relative attainment of the performance metrics described above.